Kari Ala‐Leppilampi
- Public Health, Environmental and Occupational Health
- Pharmacology top 10%
- Epidemiology
- General Health Professions
- Clinical Psychology
- Co-authors
- Janet ParsonsCheryl PritloveClara Juandó‐PratsGina StodutoRobert E. MannTony AntoniouAnca IalomiteanuJürgen Rehm
- Topics
- Cannabis and Cannabinoid Research (3 papers)Substance Abuse Treatment and Outcomes (3 papers)Cancer Immunotherapy and Biomarkers (2 papers)
- Partner nations
- CanadaUnited KingdomUnited States
In The Last Decade
Kari Ala‐Leppilampi
14 papers receiving 317 citations
Peers
Comparison fields: 5 of 87
- Public Health, Environmental and Occupational Health 115
- Pharmacology 101
- Epidemiology 71
- General Health Professions 65
- Clinical Psychology 46
Countries citing papers authored by Kari Ala‐Leppilampi
This map shows the geographic impact of Kari Ala‐Leppilampi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Ala‐Leppilampi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Ala‐Leppilampi more than expected).
Fields of papers citing papers by Kari Ala‐Leppilampi
This network shows the impact of papers produced by Kari Ala‐Leppilampi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Ala‐Leppilampi. The network helps show where Kari Ala‐Leppilampi may publish in the future.
Co-authorship network of co-authors of Kari Ala‐Leppilampi
This figure shows the co-authorship network connecting the top 25 collaborators of Kari Ala‐Leppilampi. A scholar is included among the top collaborators of Kari Ala‐Leppilampi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari Ala‐Leppilampi. Kari Ala‐Leppilampi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 6 | |
| 3 | 23 | |
| 4 | 67 | |
| 5 | 1 | |
| 6 | 96 | |
| 7 | 3 | |
| 8 | 13 | |
| 9 | 4 | |
| 10 | 18 | |
| 11 | 58 | |
| 12 | 3 | |
| 13 | 37 | |
| 14 | Control of cannabis use in western countries - A brief review of history and present | 1 |
About Kari Ala‐Leppilampi
Kari Ala‐Leppilampi is a scholar working on Biological Psychiatry, Health and Public Health, Environmental and Occupational Health, having authored 14 papers that have together received 334 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (3 papers), Substance Abuse Treatment and Outcomes (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Pharmacology (101 citations), Anesthesiology and Pain Medicine (30 citations) and Gender Studies (45 citations). Kari Ala‐Leppilampi has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include Janet Parsons, Cheryl Pritlove, Clara Juandó‐Prats, Gina Stoduto, Robert E. Mann, Tony Antoniou, Anca Ialomiteanu, Jürgen Rehm, Mina Tadrous and Tara Gomes. Their work appears in journals such as The Lancet, Annals of Oncology and Violence and Victims.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.